Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05200923 · ClinicalTrials.gov registry record · NA

Pelvic Health Electrically Evoked Recording (PEER) 2 Study

A NA study of Overactive Bladder and Fecal Incontinence, sponsored by MedtronicNeuro.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
7
Study locations

NCT05200923 is a NA study of Overactive Bladder and Fecal Incontinence that is actively recruiting participants, run by MedtronicNeuro. The registered enrollment target is 300 participants, above the 205-participant average among 45 other Overactive Bladder trials with a reported enrollment target (46% higher). The trial reports 7 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05200923, a NA study of Overactive Bladder and Fecal Incontinence, is actively recruiting participants, sponsored by MedtronicNeuro.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
7
Study locations

Study Summary

To collect physiological signals at several timepoints during the therapy evaluation period.

Interventions

  • DEVICE Sacral Neuromodulation

Study Locations (7)

Louisiana

  • LSUHSC Department of Urology - New Orleans
  • Ochsner Clinic Foundation - New Orleans

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland
  • OhioHealth Physician's Group Urology - Hilliard

Indiana

  • Indiana University Health Methodist Research Institute - Indianapolis

Minnesota

  • Mayo Clinic Urology/Urogynecology Department - Rochester

Texas

  • DHR Health Institute for Research and Development - Edinburg

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-01-18
Est. Completion 2026-12-18
Phase NA

Sponsor

MedtronicNeuro

51 total trials

What the Registry Record Tells You About NCT05200923

The ClinicalTrials.gov registry entry for NCT05200923 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 205-participant average among 45 other Overactive Bladder trials with a reported enrollment target (46% higher). The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which Sacral Neuromodulation is the first listed.

NCT05200923 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Louisiana, Ohio, Indiana.

Frequently Asked Questions

What is clinical trial NCT05200923 about?

NCT05200923 is a clinical study titled "Pelvic Health Electrically Evoked Recording (PEER) 2 Study". To collect physiological signals at several timepoints during the therapy evaluation period.

What is the current status of trial NCT05200923?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-01-18. Estimated completion is 2026-12-18.

What conditions does trial NCT05200923 study?

This clinical trial studies the following conditions: Overactive Bladder, Fecal Incontinence, Urinary Retention.

What interventions are being tested in trial NCT05200923?

The interventions under investigation include: Sacral Neuromodulation (DEVICE).

Who is sponsoring clinical trial NCT05200923?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05200923 being conducted?

This trial has 7 study locations across Indiana, Louisiana, Minnesota, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overactive Bladder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.